The role of PCA3 testing in a homogenenous population of patients with low and intermediate-risk prostate cancer treated with brachytherapy
| Autor: | Sara Martínez Breijo, Luis M. Antón Aparicio, Carlos Méndez Méndez, Venancio Chantada Abal, Manuel Ramos Vazquez, Arturo Candal Gomez, Inmaculada Ales Diaz, Sonia Aranzazu Garcia, Lorena Paris, Raquel Losada, Ana Medina, Alfonso Mariño, David Olmos, José Luis Fernández, Cristina Azpitarte |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Oncology
PCA3 Cancer Research medicine.medical_specialty Pathology education.field_of_study business.industry medicine.medical_treatment Brachytherapy Population food and beverages medicine.disease Prostate cancer Internal medicine medicine Biomarker (medicine) Urine sample education Intermediate risk business |
| Zdroj: | Journal of Clinical Oncology. 32:e16091-e16091 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2014.32.15_suppl.e16091 |
| Popis: | e16091 Background: The prostate cancer associated gene 3(PCA3) is a promising and specific prostate cancer (PCa) biomarker. PCA3 can be detected in a urine sample becoming an easy and affordable te... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|